Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: Distinct metabolic entities and cardiovascular risk?

Diabetic Medicine

Volumn 21, Issue 7, 2004, Pages 730-737

  Piche M E ^a,b   Despres J P ^a,b,c   Pascot, A ^b,c   Nadeau, A ^b   Tremblay, A ^a   Weisnagel, S J ^a,b   Bergeron, J ^b   Lemieux, S ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Cardiovascular disease risk; Impaired glucose homeostasis; Lipid lipoprotein profile; Visceral obesity; Women

Indexed keywords

APOLIPOPROTEIN B; C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOACCUMULATION; BODY COMPOSITION; BODY FAT; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREMENOPAUSE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; C-PEPTIDE; CARDIOVASCULAR DISEASES; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MIDDLE AGED; PREMENOPAUSE; RISK FACTORS;

EID: 3142693577     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01234.x     Document Type: Article

References (33)

1. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-1431.
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
3. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 1980; 1: 1373-1376.
4. Jarrett RJ, McCartney P, Keen H. The Bedford Survey, ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84.
5. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events, a metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-240.
6. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990; 10: 223-231.
7. Pascot A, Després JP, Lemieux I, Almeras N, Bergeron J, Nadeau A et al. Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation. Diabetes Care 2001; 24: 902-908.
8. Pascot A, Després JP, Lemieux I, Bergeron J, Nadeau A, Prud'homme D et al. Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Diabetologia 2000; 43: 1126-1135.
9. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impaired of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.
10. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-723.
11. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE. Cardiovascular risk profile in individuals with borderline glycemia. The effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000; 23: 278-282.
12. De Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization Criteria for the diagnosis of abnormal glucose tolerance. Diabetes Care 1998; 21: 1686-1690.
13. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 1998; 16: 212-218.
14. Larsson H, Berglund G, Lindgarde F, Ahren B. Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose tolerance. Diabetologia 1998; 41: 1124-1125.
15. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance. Lessons from the Botnia study. Diabetes 2000; 49: 975-980.
16. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2003; 26: 868-874.
17. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
18. Behnke AR, Wilmore JH. Evaluation and regulation of body build and composition. In: Englewood Cliffs. New Jersey: Prentice Hall, 1974, 20-37.
19. Siri WE. The gross composition of the body. Adv Biol Med Phys 1956; 4: 239-280.
20. Standardization of anthropometric measurements. In: Lohman T, Roche A, Martorel R, eds. The Airlie (VA) Consensus Conference. Champaign, IL: Human Kinetics Publishers, 1988, 39-80.
21. Sjöström L, Kvist H, Cederblad A, Tylen U. Determination of total adipose tissue and body fat in women by computed tomography, 40K and tritium. Am J Physiol 1986; 250: E736-E745.
22. Ferland M, Després JP, Tremblay A, Pineault S, Nadeau A, Moorjani S et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 1989; 61: 139-148.
23. Kvist H, Sjöström L, Tylen U. Adipose tissue volume determination in women by computed tomography: technical considerations. Int J Obes 1986; 10: 53-67.
24. Richterich R, Dauwalder H. Zur bestimmung der plasmaglukosekonzentration mit der hexokinase-glucose-6-phosphatdehydrogenase-methode. Schweiz Med Wochenschr 1971; 101: 615-618.
25. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 1971; 37: 732-738.
26. Heding LG. Immunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541-548.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment, insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
28. Couillard C, Després JP, Lamarche B, Bergeron J, Gagnon J, Leon AS et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001; 21: 1226-1232.
29. Gidez LI, Miller GJ, Burstein M, Slage S, Eder HH. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982; 23: 1206-1223.
30. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52.
31. Qiau Q, Hu G, Tuomilehto J, Balkau B, Bord-Johnsen K, for the DECODE Study Group. Age and sex specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. 37th Annual meeting of the European Diabetes Epidemiology Group, Oxford 2002. 2002; Abstract 37.
32. Van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H et al. Disturbances in β-cell function in impaired fasting glycemia. Diabetes 2002; 51: S265-S270.
33. Mooy JM, Gootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in general Caucasian population: the Hoorn Study. Diabetologia 1996; 39: 298-305.